These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2749014)

  • 21. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
    Hayashi Y; Ikeda U; Hashimoto T; Watanabe T; Mitsuhashi T; Shimada K
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):672-4. PubMed ID: 10234723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hands-on help Torsades de pointes.
    Dulak SB
    RN; 2004 Oct; 67(10):24ac1-4. PubMed ID: 15552376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verapamil treatment of Torsades de pointes ventricular tachyarrhythmia in particular pattern.
    Qi WH; Shi L; Gong LS
    Chin Med J (Engl); 1988 Apr; 101(4):249-50. PubMed ID: 3138082
    [No Abstract]   [Full Text] [Related]  

  • 24. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients.
    Justo D; Gal-Oz A; Paran Y; Goldin Y; Zeltser D
    Addiction; 2006 Sep; 101(9):1333-8. PubMed ID: 16911733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report].
    Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S
    J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Torsades de pointe. Apropos of 60 cases].
    Salle P; Rey JL; Bernasconi P; Quiret JC; Lombaert M
    Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):381-8. PubMed ID: 4026164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Life-threatening Torsades de Pointes resulting from "natural" cancer treatment.
    Chan CK; Chan MH; Tse ML; Chan IH; Cheung RC; Lam CW; Lau FL
    Clin Toxicol (Phila); 2009 Jul; 47(6):592-4. PubMed ID: 19586358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fast and slow torsade de pointes--electrocardiographic characteristics.
    Kukla P; Słowiak-Lewińska T; Szczuka K; Plato A; Bromblik A; Hajduk B; Kluczewski M; Przewor M
    Kardiol Pol; 2004 Apr; 60(4):342-7. PubMed ID: 15226783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone-induced torsade de pointes in a patient with normal baseline QT interval.
    Almehmi A; Malas AM; Yousufuddin M; Rosencrance JG
    W V Med J; 2004; 100(4):147-8. PubMed ID: 15471174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Classification and treatment of torsades de pointes (TdP): a report of 11 cases].
    Mei KZ; Sun AH; Li BJ
    Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):28-30. PubMed ID: 8404313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiarrhythmic effects of intravenous magnesium sulfate in torsade de pointes. Apropos of 6 cases].
    Etienne Y; Blanc JJ; Songy B; Boschat J; Guiserix J; Etienne E; Egreteau JP; Penther P
    Arch Mal Coeur Vaiss; 1986 Mar; 79(3):362-7. PubMed ID: 3087320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Torsades de pointes" and atrioventricular block.
    Moroe K; Saku K; Tashiro N; Hiroki T; Arakawa K
    Clin Cardiol; 1988 Jan; 11(1):9-13. PubMed ID: 3349663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disopyramide-induced Torsade de Pointes.
    Tzivoni D; Keren A; Stern S; Gottlieb S
    Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study of amiodarone-associated torsade de pointes in Chinese people.
    Geng DF; Jin DM; Wang JF; Luo YJ; Wu W
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):712-8. PubMed ID: 16884506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
    Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
    Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
    Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degenerating regenerating torsades de pointes.
    Perrin MJ; Gollob MH; Birnie DH; Nery PB; Keren A
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):e80-3. PubMed ID: 22469253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsades de pointes in paced patients with sick sinus syndrome after disopyramide administration.
    Kimura Y; Takayanagi K; Sakai Y; Satoh T; Fujito T; Inoue T; Hayashi T; Morooka S; Takabatake Y
    Jpn Heart J; 1994 Mar; 35(2):153-61. PubMed ID: 8022060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.